4月1日周二，丽珠医药（01513）股价盘中大涨5.08%，引发市场关注。这一显著涨幅背后，可能与南向资金的持续增持有关。
根据最新数据显示，3月31日，南向资金增持丽珠医药11.36万股，这已经是连续第三个交易日增持该股。截至3月31日收盘，港股通共持有丽珠医药6134.75万股，占流通股的19.98%。这一持续的买入行为可能是推动丽珠医药股价上涨的重要因素。
分析人士指出，南向资金的持续流入反映了内地投资者对丽珠医药未来发展前景的信心。随着持股比例的不断提高，南向资金对丽珠医药股价的影响力也在增强。投资者应密切关注南向资金的动向，同时也要注意公司基本面的变化，以及医药行业的整体发展趋势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.